Send to

Choose Destination
Data Brief. 2015 Jun 3;4:199-202. doi: 10.1016/j.dib.2015.05.014. eCollection 2015 Sep.

Transcriptomic changes in mouse embryonic stem cells exposed to thalidomide during spontaneous differentiation.

Author information

Division of Toxicology, Office of Applied Research and Safety Assessment, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, Laurel, MD, USA.


Thalidomide is a potent developmental toxicant that induces a range of birth defects, notably severe limb malformations. To unravel the molecular mechanisms underpinning the teratogenic effects of thalidomide, we used microarrays to study transcriptomic changes induced by thalidomide in an in vitro model based on the differentiation of mouse embryonic stem cells (mESCs), and published the major findings in a research article entitled "Thalidomide induced early gene expression perturbations indicative of human embryopathy in mouse embryonic stem cells" [1]. The data presented herein contains complementary information related to the aforementioned research article.


Developmental toxicity; Differentiation; Embryonic stem cell; Microarray; Mouse; Thalidomide; Transcriptomics

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center